Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism
Table 1
Reaction conditions for measurement of DPP-2, DPP-8, DPP-9, PEP, and FAPα activities.
Click through the PLOS taxonomy to find articles in your field.
For more information about PLOS Subject Areas, click here.
Reaction conditions for measurement of DPP-2, DPP-8, DPP-9, PEP, and FAPα activities.